National Medical Care Company (4005.SR)
SAR 146.8
(-2.0%)
SAR 146.8
(-2.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 323.02 Million SAR | 22.43% |
| 2022 | 244.18 Million SAR | 17.79% |
| 2021 | 214.55 Million SAR | 21.17% |
| 2020 | 179.49 Million SAR | -1.84% |
| 2019 | 174.87 Million SAR | 7.56% |
| 2018 | 159.34 Million SAR | -6.32% |
| 2017 | 171.23 Million SAR | 118.76% |
| 2016 | 137.09 Million SAR | -64.26% |
| 2015 | 187.36 Million SAR | 51.89% |
| 2014 | 144.97 Million SAR | 17.1% |
| 2013 | 131.05 Million SAR | -8.38% |
| 2012 | 135.13 Million SAR | 10.36% |
| 2011 | 121.32 Million SAR | 18.52% |
| 2010 | 115.48 Million SAR | 35.6% |
| 2009 | 84.27 Million SAR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 87.99 Million SAR | -8.15% |
| 2024 Q3 | 70.86 Million SAR | 4.05% |
| 2024 Q1 | 87.66 Million SAR | 17.72% |
| 2023 Q1 | 74.49 Million SAR | 4.64% |
| 2023 Q3 | 97.1 Million SAR | 38.67% |
| 2023 Q4 | 72.62 Million SAR | -25.21% |
| 2023 FY | - SAR | 22.43% |
| 2023 Q2 | 70.02 Million SAR | -6.0% |
| 2022 FY | - SAR | 17.79% |
| 2022 Q1 | 47.01 Million SAR | -4.34% |
| 2022 Q4 | 71.19 Million SAR | 15.19% |
| 2022 Q3 | 61.8 Million SAR | 8.11% |
| 2022 Q2 | 57.17 Million SAR | 21.62% |
| 2021 Q2 | 50.05 Million SAR | -8.49% |
| 2021 Q4 | 49.14 Million SAR | -6.34% |
| 2021 FY | - SAR | 21.17% |
| 2021 Q1 | 54.7 Million SAR | 77.42% |
| 2021 Q3 | 52.47 Million SAR | 4.82% |
| 2020 Q3 | 38.11 Million SAR | -18.01% |
| 2020 Q2 | 46.49 Million SAR | -15.28% |
| 2020 Q4 | 30.83 Million SAR | -19.11% |
| 2020 FY | - SAR | -1.84% |
| 2020 Q1 | 54.87 Million SAR | 30.17% |
| 2019 Q2 | 37.73 Million SAR | -29.52% |
| 2019 Q4 | 42.15 Million SAR | 5.21% |
| 2019 FY | - SAR | 7.56% |
| 2019 Q1 | 53.54 Million SAR | 58.43% |
| 2019 Q3 | 40.06 Million SAR | 6.17% |
| 2018 Q2 | 25.9 Million SAR | -19.23% |
| 2018 FY | - SAR | -6.32% |
| 2018 Q4 | 33.79 Million SAR | 92.23% |
| 2018 Q3 | 17.58 Million SAR | -32.14% |
| 2018 Q1 | 32.07 Million SAR | 189.4% |
| 2017 Q4 | -35.87 Million SAR | -176.38% |
| 2017 FY | - SAR | 118.76% |
| 2017 Q1 | 16.7 Million SAR | 113.7% |
| 2017 Q2 | 22.67 Million SAR | 35.73% |
| 2017 Q3 | 46.96 Million SAR | 107.1% |
| 2016 Q4 | -121.98 Million SAR | -342.14% |
| 2016 Q1 | 67.2 Million SAR | 33.5% |
| 2016 Q2 | 59.82 Million SAR | -10.98% |
| 2016 Q3 | 50.37 Million SAR | -15.79% |
| 2016 FY | - SAR | -64.26% |
| 2015 FY | - SAR | 51.89% |
| 2015 Q2 | 64.95 Million SAR | 41.94% |
| 2015 Q4 | 50.33 Million SAR | -0.88% |
| 2015 Q3 | 50.78 Million SAR | -21.82% |
| 2015 Q1 | 45.76 Million SAR | -36.91% |
| 2014 Q3 | 39.75 Million SAR | -22.11% |
| 2014 Q1 | 42.98 Million SAR | 39.41% |
| 2014 FY | - SAR | 17.1% |
| 2014 Q4 | 72.54 Million SAR | 82.46% |
| 2014 Q2 | 51.04 Million SAR | 18.75% |
| 2013 Q3 | 25.04 Million SAR | -13.76% |
| 2013 Q2 | 29.03 Million SAR | -24.26% |
| 2013 Q1 | 38.33 Million SAR | 23.32% |
| 2013 FY | - SAR | -8.38% |
| 2013 Q4 | 30.83 Million SAR | 23.14% |
| 2012 Q3 | 28.48 Million SAR | 0.0% |
| 2012 Q4 | 31.08 Million SAR | 9.12% |
| 2012 FY | - SAR | 10.36% |
| 2011 FY | - SAR | 18.52% |
| 2010 FY | - SAR | 35.6% |
| 2009 FY | - SAR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Mouwasat Medical Services Company | 986.81 Million SAR | 67.266% |
| Dallah Healthcare Company | 631.92 Million SAR | 48.883% |
| Al Hammadi Company For Development and Investment | 438.27 Million SAR | 26.298% |
| Middle East Healthcare Company | 551.23 Million SAR | 41.401% |
| Dr. Sulaiman Al Habib Medical Services Group Company | 2.54 Billion SAR | 87.305% |
| Canadian General Medical Center Complex Company | 19.92 Million SAR | -1521.309% |
| Arabian International Healthcare Holding Company | 111.1 Million SAR | -190.731% |
| Future Care Trading Co. | 15.6 Million SAR | -1969.572% |
| Naba Alsaha Medical Services Company | 65.27 Million SAR | -394.829% |
| Lana Medical Co. | 4.56 Million SAR | -6972.281% |
| Al-Modawat Specialized Medical Co. | 20.76 Million SAR | -1455.342% |